Search results

Page title matches

• FDA Consumer
  ...rom 1967 to 1972 it was known as ''FDA Papers'' before changing title to ''FDA Consumer'' with v.6 #6 (July/August 1972). ...depository library|depository libraries]] which selected to receive it. ''FDA Consumer'' ceased publication with v.41 #2 (March-April 2007), though exist
  861 bytes (116 words) - 18:09, 9 December 2011

Page text matches

• Quinine
  ...ramps]]. This practice is now considered dubious by the FDA<ref>http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders ...sumers About Off-Label Use of Quinine to Treat Leg Cramps | url=http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108799.htm | accessdate=
  27 KB (3,844 words) - 16:41, 27 September 2010
• Mefloquine
  1. "At the time this study was conceived, no formal FDA guidelines for neurotoxicity testing existed. In contrast, first-tier neuro The FDA "approval" process in 1970 did not require safety testing for neurotoxicity
  13 KB (1,807 words) - 16:41, 27 September 2010
• Deferoxamine
  ...(an excess of aluminium in the body) in select patients although it is not FDA approved for this use.
  5 KB (714 words) - 20:14, 21 September 2010
• Naloxone
  | UNII_Ref = {{fdacite|correct|FDA}} ...FDA Approves Narcan Nasal Spray|url = http://www.jems.com/articles/2015/11/fda-approves-narcan-nasal-spray.html|website = www.jems.com|accessdate = 2015-1
  33 KB (4,541 words) - 10:57, 17 June 2016
• Carbamazepine
  In the United States, the [[Food and Drug Administration|FDA]]-approved indications for carbamazepine use are [[epilepsy]] (including [[ ...for Drugs, Biologics, Medical Devices, and Dietary Supplements |publisher=FDA}}</ref> In Europeans a large proportion of sensitivity is associated with [
  16 KB (2,164 words) - 16:42, 27 September 2010
• Phenobarbital
  ...ov/fdac/features/2007/107_drug.html |date=January-February 2007 |publisher=FDA Consumer magazine |accessdate=2007-09-27}}</ref>
  20 KB (2,657 words) - 16:42, 27 September 2010
• Phenytoin
  ...ilization]], although it has never been approved for those purposes by the FDA. [[Jack Dreyfus]], founder of the [[Dreyfus Fund]], became a major proponen ...at the FDA has identified a potential safety issue, but does not mean that FDA has identified a causal relationship between the drug and the listed risk.
  12 KB (1,686 words) - 16:42, 27 September 2010
• Albendazole
  ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA) has not approved albendazole for this indication. It is marketed by [[Glax
  10 KB (1,261 words) - 13:28, 4 September 2010
• Clindamycin
  ...ef>{{cite web | url = http://www.medscape.com/viewarticle/548709 | title = FDA Approvals: Ziana, Kadian, Polyphenon E | last = Waknine | first = Yael | da
  25 KB (3,261 words) - 14:17, 11 September 2010
• Doxycycline
  ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA) approval in 1967, becoming Pfizer's first once-a-day broad-spectrum antibi
  20 KB (2,578 words) - 16:43, 27 September 2010
• Metronidazole
  ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA) approved) *[[Crohn's disease]] with colonic or perianal involvement (non-FDA approved){{ndash}} believed to be more effective in combination with [[cipr
  19 KB (2,528 words) - 16:43, 27 September 2010
• Nitrofurantoin
  ...of the Council Regulation 2377/90. The [[Food and Drug Administration]] (FDA) of the United States has prohibited [[furaltadone]] since February 1985 an
  12 KB (1,576 words) - 16:43, 27 September 2010
• Vancomycin
  ...nd's being fast-tracked for approval by the [[Food and Drug Administration|FDA]] in 1958. Eli Lilly first marketed vancomycin hydrochloride under the trad ...rmacare]] in Australia. The [[patent]] expired in the early 1980s, but the FDA has not authorized the sale of any generic versions in the USA.
  31 KB (4,198 words) - 16:43, 27 September 2010
• Clofazimine
  ...government named Clofazimine an [[orphan drug]] in June 1986. Geigy gained FDA approval for the drug in December 1986. ...its immunosuppressive activity even before it was approved for leprosy by FDA. It was first reported to be effective in treating chronic discoid lupus er
  12 KB (1,651 words) - 16:43, 27 September 2010
• Fluconazole
  Fluconazole/Diflucan is in the FDA pregnancy category C. <br />This means that it is not known whether it will
  11 KB (1,533 words) - 16:44, 27 September 2010
• Potassium iodide
  FDA-approved dosing of potassium iodide for this purpose with iobenguane, is as ...s/Guidance%20for%20use%20of%20KI%20for%20nuclear%20emergency%20USG.pdf] US FDA, "Potassium Iodide as a Thyroid Blocking Agent in Radiation Emergencies," U
  23 KB (3,281 words) - 16:44, 27 September 2010
• Abacavir
  Abacavir was approved by the [[Food and Drug Administration]] (FDA) on December 18, 1998 and is thus the fifteenth approved antiretroviral dru A new FDA alert concerning abacavir and abacavir containing medications
  8 KB (1,124 words) - 16:44, 27 September 2010
• Didanosine
  ...ates by the [[Food and Drug Administration]] (FDA) on October 9, 1991. Its FDA approval helped bring down the price of [[zidovudine]] (AZT), the initial a ...oul-tasting and the buffering compound would cause diarrhea. Although the FDA had not approved the original formulation for once-a-day dosing it was poss
  9 KB (1,239 words) - 16:44, 27 September 2010
• Emtricitabine
  ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA) on July 12, 2006 under the brand name '''Atripla'''. It was approved by the FDA July 2, 2003. It is very similar to [[3TC]] and cross-resistance between th
  5 KB (667 words) - 16:44, 27 September 2010
• Lamivudine
  Lamivudine was approved by the [[Food and Drug Administration]] (FDA) on November 17, 1995 for use with [[zidovudine]] (AZT) and again in 2002 a
  9 KB (1,248 words) - 16:44, 27 September 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)